Your browser doesn't support javascript.
loading
Aspiration pneumonia.
Niederman, M S; Cilloniz, C.
Affiliation
  • Niederman MS; Professor. Michael S. Niederman, Division of Pulmonary and Critical Care Medicine, New York Presbyterian, Weill Cornell Medical Center, New York, USA. msn9004@med.cornell.edu.
Rev Esp Quimioter ; 35 Suppl 1: 73-77, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35488832
ABSTRACT
The growing population of older people worldwide represents a great challenge for health systems. The elderly are at increased risk of infectious diseases such as pneumonia, which is associated with increased morbidity and mortality related mainly to age-related physiological changes in the immune system (immunosenescence), the presence of multiple chronic comorbidities, and frailty. In pneumonia, microaspiration is recognized as the main pathogenic mechanism; while macroaspiration which refers to the aspiration of a large amount of oropharyngeal or upper gastrointestinal content passing through the vocal cords and trachea into the lungs is identified as "aspiration pneumonia". Although there are strategies for the prevention and management of patients with pneumonia that have been shown to be effective in older people with pneumonia, more research is needed on aspiration pneumonia, its risk factors and outcomes, especially since there are no specific criteria for its diagnosis and consequently, the studies on aspiration pneumonia include heterogeneous populations.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Pneumonia, Aspiration Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Pneumonia, Aspiration Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: United States